XM does not provide services to residents of the United States of America.

What to Watch in the Day Ahead - Wednesday, October 16



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>What to Watch in the Day Ahead - Wednesday, October 16</title></head><body>

The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US. Thomson One users can register at RT/DAY/US. All times in ET/GMT

Morgan Stanley will report its third-quarter results. Analysts expect higher profit, helped by a fertile environment for dealmaking.


The Labor Department is expected to report import prices fell 0.4% in September, following a 0.3% decrease in August. Export prices likely declined 0.4% in September, compared with a 0.7% drop in August.


U.S. Bancorp is expected to report a fall in third-quarter profit, as its interest income shrinks due to subdued loan demand and higher deposit costs. Separately, Citizens Financial is scheduled to report a lower third-quarter profit as the bank shells out more to hold onto customers' deposits. Also, Synchrony Financial is set to report its third-quarter results. Analysts expect a rise in profit, helped by net interest income.


Abbott Laboratories is expected to report its third-quarter results. Investor focus will be on the performance of its heart devices and continuous glucose monitors.


Kinder Morgan will announce third-quarter results after markets close, with its net income expected to come in higher than its year-ago income.


Railroad operator CSX Corp is expected to report higher third-quarter revenue and profit.


Statistics Canada is due to report the country's factory sales, which likely fell 1.5% in August, compared with a 1.4% gain in July. Separately, the Canadian Mortgage and Housing Corporation is scheduled to release data on housing starts which likely grew to a seasonally adjusted annualized rate of 237,500 units in September from 217,400 units recorded in August.


LIVECHAT - REUTERS GLOBAL MARKETS FORUM

Equities Watch with Reuters market correspondents in London and New York. (1000/1400) To join the conversation, email us here



Compiled by Nachiket Tekawade in Bengaluru; Editing by Vijay Kishore

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.